Search research articles
Contact Us
Filters
Showing results (1-10 of 149) with videos related to
Page
of 15
Sort By:
Pharmaceutical Statistics
|
September 23, 2021
Semi-parametric accelerated failure-time model: A useful alternative to the proportional-hazards model in cancer clinical trials
Tomasz Burzykowski
Statistical Methods in Medical Research
|
April 17, 2008
Surrogate endpoints: wishful thinking or reality?
Tomasz Burzykowski
Statistical Applications in Genetics and Molecular Biology
|
December 6, 2014
A hidden Markov-model for gene mapping based on whole-genome next generation sequencing data
Jürgen Claesen, Tomasz Burzykowski
Mass Spectrometry Reviews
|
September 8, 2016
Computational methods and challenges in hydrogen/deuterium exchange mass spectrometry
Jürgen Claesen, Tomasz Burzykowski
World Neurosurgery
|
January 25, 2022
Relationship Among the Foraminal Area and Demographic and Clinical Characteristics of Patients with Low Back Pain
Tomasz Lorenc, Tomasz Burzykowski
Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|
January 6, 2005
Predicted and observed thyroid cancer incidence in Poland after year 1986
Tomasz Burzykowski, Wiktor Chmielarczyk
Pharmaceutical Statistics
|
November 4, 2006
Surrogate threshold effect: an alternative measure for meta-analytic surrogate endpoint validation
Tomasz Burzykowski, Marc Buyse
Pharmaceutical Statistics
|
February 11, 2010
The correlation structure of longitudinal measurements of vision in patients with macular degeneration
Tomasz Burzykowski, M Buyse
Statistical Applications in Genetics and Molecular Biology
|
February 5, 2011
A Markov-chain model for the analysis of high-resolution enzymatically 18O-labeled mass spectra
Dirk Valkenborg, Tomasz Burzykowski
Journal of the American Society for Mass Spectrometry
|
April 8, 2011
A Bayesian Markov-chain-based heteroscedastic regression model for the analysis of 18O-labeled mass spectra
Qi Zhu, Tomasz Burzykowski
Page
of 15
Search research articles
Search
Showing results (1-10 of 149) with videos related to
Sort By:
Page
of 15
Pharmaceutical Statistics
|
September 23, 2021
Semi-parametric accelerated failure-time model: A useful alternative to the proportional-hazards model in cancer clinical trials
Tomasz Burzykowski
Statistical Methods in Medical Research
|
April 17, 2008
Surrogate endpoints: wishful thinking or reality?
Tomasz Burzykowski
Statistical Applications in Genetics and Molecular Biology
|
December 6, 2014
A hidden Markov-model for gene mapping based on whole-genome next generation sequencing data
Jürgen Claesen, Tomasz Burzykowski
Mass Spectrometry Reviews
|
September 8, 2016
Computational methods and challenges in hydrogen/deuterium exchange mass spectrometry
Jürgen Claesen, Tomasz Burzykowski
World Neurosurgery
|
January 25, 2022
Relationship Among the Foraminal Area and Demographic and Clinical Characteristics of Patients with Low Back Pain
Tomasz Lorenc, Tomasz Burzykowski
Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|
January 6, 2005
Predicted and observed thyroid cancer incidence in Poland after year 1986
Tomasz Burzykowski, Wiktor Chmielarczyk
Pharmaceutical Statistics
|
November 4, 2006
Surrogate threshold effect: an alternative measure for meta-analytic surrogate endpoint validation
Tomasz Burzykowski, Marc Buyse
Pharmaceutical Statistics
|
February 11, 2010
The correlation structure of longitudinal measurements of vision in patients with macular degeneration
Tomasz Burzykowski, M Buyse
Statistical Applications in Genetics and Molecular Biology
|
February 5, 2011
A Markov-chain model for the analysis of high-resolution enzymatically 18O-labeled mass spectra
Dirk Valkenborg, Tomasz Burzykowski
Journal of the American Society for Mass Spectrometry
|
April 8, 2011
A Bayesian Markov-chain-based heteroscedastic regression model for the analysis of 18O-labeled mass spectra
Qi Zhu, Tomasz Burzykowski
Page
of 15